medigraphic.com
ISSN 1405-1699 (Impreso)
Órgano Oficial del Colegio Mexicano de Alergia, Asma e Inmunología Pediátrica y de la Asociación Latinoamericana de Pediatría

2018, Número 1

<< Anterior

Alerg Asma Inmunol Pediatr 2018; 27 (1)


Uso de metotrexato en niños con dermatitis atópica severa, presentación de 3 casos

Navarrete SFP, Rojas PO

Idioma: Español
Referencias bibliográficas: 33
Paginas: 25-31
Archivo PDF: 207.41 Kb.


RESUMEN

La dermatitis atópica o eccema atópico, es hasta ahora una enfermedad compleja y poco entendida, tiene una amplia gama de manifestaciones clínicas dermatológicas, edad de presentación y condiciones asociadas. Con diversos tratamientos según estas diferencias. En casos leves a moderados; el uso de cremas emolientes, baños, antihistamínicos, esteroides tópicos y cremas de inhibidores de calcineurina son la primera línea de tratamiento. Un paciente padece de dermatitis atópica severa si su índice de SCORAD es mayor de 40. Estos pacientes no tienen un tratamiento universalmente aceptado. Este artículo describe a 3 pacientes pediátricos con dermatitis atópica severa tratados con éxito a dosis de bajas a medianas de metotrexato con mínimas complicaciones.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Lyons JJ, Milner JD, Stone KD. Atopic dermatitis in children: clinical features, pathophysiology, and treatment. Immunol Allergy Clin North Am. 2015; 35 (1): 161-183. doi:10.1016/j. iac.2014.09.008

  2. Muraro A, Lemanske RF Jr, Hellings PW, Akdis CA, Bieber T, Casale TB et al. Precision medicine in patients with allergic diseases: airway diseases and atopic dermatitis-PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology. J Allergy Clin Immunol. 2016; 137 (5). 1347-1358. doi: 10.1016/j.jaci.2016.03.010

  3. Celakovská J, Bukač J. The severity of atopic dermatitis evaluated with the SCORAD index and the occurrence of bronchial asthma and rhinitis, and the duration of atopic dermatitis. Allergy Rhinol (Providence). 2016; 7: 8-13. doi:10.2500/ar.2016.7.0144

  4. Fitzpatrick TB, Goldsmith LA, Wolff K. Fitzpatrick’s dermatology in general medicine. New York: McGraw-Hill, 2012.

  5. Sidbury R, Davis DM, Cohen DE, Cordoro KM, Berger TG, Bergman JN et al. Guidelines of care for the management of atopic dermatitis: section 3, management and treatment with phothoterapy and systemic agents. J Am Acad Dermatol. 2014; 71 (2): 327-349. doi:10.1016/j. jaad.2014.03.030

  6. Zoller L, Ramon M, Bergman R. Low dose methotrexate therapy is effective in late-onset atopic dermatitis and idiopathic eczema. Isr Med Assoc J. 2014; 10 (43): 413- 414.

  7. El-Khalawany MA, Hassan H, Shaaban D, Ghonaim N, Eassa B. Methotrexate versus cyclosporine in the treatment of severe atopic dermatitis in children: a multicenter experience from Egypt. Eur J Pediatr. 2013; 172: 351-356. doi:10.1007/ s00431-012-1893-3

  8. Sánchez J, Páez B, Macías A, Olmos C, De Falco A. Atopic dermatitis guideline. Position paper from the Latin American Society of Allergy, Asthma and Immunology. Rev Alerg Mex. 2014; 61: 178-211.

  9. Agrawal R, Woodfolk JA. Skin barrier defects in atopic dermatitis. Curr Allergy Asthma Rep. 2014; 14 (5): 433.

  10. Consenso Nacional de Dermatitis Atópica 2013. Arch Argent Pediat. 2014. 1-21 doi: 10.5546/aap.2014.293

  11. Kim DH, Li K, Seo SJ, Jo SJ, Yim HW, Kim CM et al. Quality of life and disease severity are correlated in patients with atopic dermatitis. J Korean Med Sci. 2012; 27 (11): 1327. doi: 10.3346/jkms.2012.27.11.1327

  12. Einchenfield LF, Tom WL, Berger TG, Krol A, Paller AS, Schwarzenberger K et al. Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopica dermatitis with topical therapies. J Am Acad Dermatol. 2014; 71: 116-132. doi: 10.1016/ jaad.2014.03.023.epub 2014 May 9.

  13. Severity scoring of atopic dermatitis: the SCORAD Index. Consensus report of the european task force on atopic dermatitis. Dermatology. 1993; 186 (1): 23-31. doi: 10.1159/000247298

  14. Boguniewicz M, Leung DY. The ABC’s of managing patients with severe atopic dermatitis. J Allergy Clin Immunol. 2013; 132: 2511-2-e5. doi:10.1016/j.jaci.2013.06.030

  15. Walling HW, Swick BL. Update on the management of chronic eczema: new approaches and emerging treatment options. Clin Cosmet Investig Dermatol. 2010; 99-117. doi: 10.2147/ccid.s6496

  16. Kim JE, Kim HJ, Lew BL, Lee KH, Hong SP, Jang YH et al. Consensus guidelines for the treatment of atopic dermatitis in Korea (Part II): systemic treatment. Ann Dermatol. 2015; 27 (5): 578-592.

  17. Deo M, Yung A, Hill S, Rademaker M. Methotrexate for treatment of atopic dermatitis in children and adolescents. Int J Dermatol. 2014; 53: 1037-1041. doi:10.1111/ ijd.12314

  18. Sidbury R, Tom WL, Bergman JN, Cooper KD, Silverman RA, Berger TG, Eichenfield, L. F. Guidelines of care for the management of atopic dermatitis. J Am Acad Dermatology. 2014; 71 (6): 1218-1233. doi:10.1016/j. jaad.2014.08.038

  19. Thomsen SF. Atopic dermatitis: natural history, diagnosis, and treatment. ISRN Allergy. 2014; 2014: 354250.

  20. Galli E, Neri I, Ricci G, Baldo E, Barone M, Fortina AB, Eichenfield LF et al. Consensus conference on clinical management of pediatric atopic dermatitis. Ital J Pediatr Italian. 2016; 42: 26. doi:10.1186/s13052-016-0229-8

  21. CENTEC. Tratamiento de la dermatitis atópica, Guía de Referencia Rápida. Catálogo Maestro de Guías de Práctica Clínica IMSS-706-14. [Internet] Disponible en: http://www. cenetec.salud.gob.mx/descargas/gpc/CatalogoMaestro/ IMSS-706-14-TxDermatitisatopica/706GER.pdf

  22. Beirana-Palencia A. Educación Médica Continua. Dermatitis atópica. Rev Cent Dermatol Pascua. 1999; 8 (3): 169-178.

  23. Rodríguez-Flores FA, Serrano-Medina E, Flores Sandoval G, Orea M y cols. Efecto terapéutico del factor de transferencia en el tratamiento de pacientes con dermatitis atópica severa. Alerg Asma e Inmunol Pediatr. 2002; 11: 9-11.

  24. Martínez MF, Leis-Dosil V, Alfageme-Roldán F, Paravisini A, Sánchez-Ramón S, Fernández RS. Omalizumab en el tratamiento de la dermatitis atópica. Actas DermoSifi liográfi cas. 103(7), 624-628. doi:10.1016/j.ad.2011.07.013

  25. Giannini EH, Cassidy JT, Brewer EJ, Shaikov A, Maximov A, Kuzmina N. Comparative effi cacy and safety of advancer drug therapy in children with juvenile rheumatoid arthritis. Semin Arthritis Rheum. 1993; 23 (819): 34-46.

  26. Ramanan AV, Dick AD, Benton D, Compeyrot-Lacassagne S, Dawoud D, Hardwick B et al. A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis (SYCAMORE Trial). Trials. 2014; 15 (1): 14. doi:10.1186/1745-6215-15-14

  27. Stoll ML, Cron RQ. Treatment of juvenile idiopathic arthritis: a revolution in care. Pediatr Rheumatol Online J. 2014; 12: 13. doi:10.1186/1546-0096-12-13

  28. Park YW, Yeom KB, Kim KH. Refractory atopic dermatitis in childhood: improvement with methotrexate? Ann Dermatol. 2013; 25 (1): 114-116. doi:10.5021/ ad.2013.25.1.114

  29. Lyakhovitsky A, Barzilai A, Heyman R, Baum S, Amichai B, Solomon M et al. Low-dose methotrexate treatment for moderate-to-severe atopic dermatitis in adults. J Eur Acad Dermatol Venereol. 2010; 24 (1): 43-49.

  30. Bronckers IM, Paller AS, van Geel MJ, van de Kerkhof PC, Seyger MM. Psoriasis in children and adolescents: diagnosis, management and comorbidities. Paediatr Drugs. 2015; 17 (5): 373-384.

  31. Politiek K, Van der Schaft J, Coenraads P, De BruinWeller MS, Schuttelaar ML. Drug survival for methotrexate in a daily practice cohort of adult patients with severe atopic dermatitis. Br J Dermatol. 2015; 174 (1): 201-203. doi:10.1111/bjd.13961

  32. Ruemmele F, Veres G, Kolho K, Griffiths A, Levine A, Escher J et al. Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn’s disease. J Crohns Colitis. 2014; 8 (10): 1179-1207. doi:10.1016/j. crohns.2014.04.005

  33. Klein A, Kaul I, Foeldvari I, Ganser G, Urban A, Horneff G. Effi cacy and safety of oral and parenteral methotrexate therapy in children with juvenile idiopathic arthritis: an observational study with patients from the german methotrexate registry. Arthritis Care Res (Hoboken). 2012; 64 (9): 1349-1356. doi:10.1002/acr.21697




2020     |     www.medigraphic.com